Validation of the Odesa Criteria 2026 (OC26) for the Diagnosis of Autoimmune Pancreatitis
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
This ambispective observational study aims to validate the Odesa Criteria 2026 (OC26), a flexible domain-based point scoring system for diagnosing autoimmune pancreatitis. The study evaluates diagnostic accuracy and reproducibility of OC26 across clinical, serological, morphological, and histological domains.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults (≥18 years) undergoing evaluation for suspected autoimmune pancreatitis.
• Availability of clinical, serological, imaging, and/or histological data required for OC26 scoring.
• Ability to provide informed consent (for prospective participants).
Locations
Other Locations
Ukraine
Military Medical Clinical Center of the Southern Region
RECRUITING
Odesa
Military Medical Clinical Center of the Southern Region
RECRUITING
Odesa
Contact Information
Primary
Oleg Dovbenko, MD, PhD
dovbenko2015@hotmail.com
+380682539685
Backup
Oleg Dovbenko, MD, PhD
dovbenko73@gmail.com
+380682539685
Time Frame
Start Date: 2026-05-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 82
Treatments
AIP Suspected Cohort
Patients evaluated for suspected autoimmune pancreatitis. Participants undergo standard clinical, serological, imaging, and histological assessment according to the Odesa Criteria 2026 (OC26). No interventions are assigned as this is an observational study.
Related Therapeutic Areas
Sponsors
Leads: Military Medical Clinical Center of the Southern Region, Ukraine